Mary Haas
Company: Regeneron Pharmaceuticals Inc
Job title: Senior Manager, Cardiovascular Metabolic & Skeletal Disease Genetics
Seminars:
Employing Human Genetics to Enable the Discovery of CIDEB as a Novel Therapeutic for NAFLD in Humans 1:40 pm
Demonstrating the value of human genetics in enhancing therapeutic development Utilising different types of genetic analyses in target discovery Discovery of CIDEB as a novel gene that influences NAFLD in humans and development of CIDEB therapeuticsRead more
day: Day 2 Seminar B Post-Lunch Tracks